Anemia study in chronic kidney disease in China
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study looks at how common anemia is in people with chronic kidney disease in China. It may help doctors better understand and manage anemia for patients with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic kidney disease, kidney failure, or chronic nephritis.
- You are on hemodialysis or peritoneal dialysis for kidney failure.
- You have at least 2 blood tests showing low kidney function (eGFR under 60) taken at least 3 months apart.
- Your anemia is not caused by recent trauma, major bleeding, or a nutritional deficiency.
- You do not have acute kidney disease without chronic kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people with chronic kidney disease (CKD) and also from some people without CKD but with kidney risk factors. It helps doctors understand how CKD develops and how it’s managed in everyday life, not to test a new drug.
This study is testing a new way to manage anemia (low red blood cells) in people on long-term dialysis. It aims to improve how doctors treat this common issue.
This study looks at how coordinated care and diet tracking affect people with chronic kidney disease (CKD), including those on dialysis. It aims to find better ways to manage the condition and improve quality of life.
This trial tests an oral medication (AND017) for anemia caused by chronic kidney disease. It aims to improve red blood cell levels without needing dialysis or current anemia treatments.
This study is looking at the link between kidney disease and heart disease. It aims to understand how heart problems affect people with chronic kidney disease. The trial does not test a new drug, but rather follows patients to learn more about their health.
This study tests two medicines (daprodustat and epoetin alfa) to see which one works better for treating low red blood cell counts (anemia) in people with chronic kidney disease who are not on dialysis yet. Both medicines aim to increase hemoglobin and reduce fatigue.
Hear when a new Anemia in Chronic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.